about
Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humansDemonstration of IS711 transposition in Brucella ovis and Brucella pinnipedialisFunctional characterization of the incomplete phosphotransferase system (PTS) of the intracellular pathogen Brucella melitensisA single amino acid change in the transmembrane domain of the VirB8 protein affects dimerization, interaction with VirB10 and Brucella suis virulenceConfinement of a β-barrel protein in nanoperforated free-standing nanomembranes for ion transport.Towards a universal method for protein refolding: the trimeric beta barrel membrane Omp2a as a test case.Structural analysis of Brucella abortus RicA substitutions that do not impair interaction with human Rab2 GTPase.Molecular targets for rapid identification of Brucella spp.Comparative proteomics analyses reveal the virB of B. melitensis affects expression of intracellular survival related proteins.Genome degradation in Brucella ovis corresponds with narrowing of its host range and tissue tropism.Identification of an unusual Brucella strain (BO2) from a lung biopsy in a 52 year-old patient with chronic destructive pneumonia.Characterization of novel Brucella strains originating from wild native rodent species in North Queensland, AustraliaIdentification of the essential Brucella melitensis porin Omp2b as a suppressor of Bax-induced cell death in yeast in a genome-wide screening.Requirement of MgtC for Brucella suis intramacrophage growth: a potential mechanism shared by Salmonella enterica and Mycobacterium tuberculosis for adaptation to a low-Mg2+ environment.The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent miceMechanism of Asp24 upregulation in Brucella abortus rough mutant with a disrupted O-antigen export system and effect of Asp24 in bacterial intracellular survival.MyD88 and STING signaling pathways are required for IRF3-mediated IFN-β induction in response to Brucella abortus infectionThe Brucella suis virB operon is induced intracellularly in macrophages.Identification of a new virulence factor, BvfA, in Brucella suis.The alkylation response protein AidB is localized at the new poles and constriction sites in Brucella abortusProduction and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: a first step towards food-grade live vaccines against brucellosisThe IncP island in the genome of Brucella suis 1330 was acquired by site-specific integration.Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen.BmaC, a novel autotransporter of Brucella suis, is involved in bacterial adhesion to host cells.Early transcriptional responses of bovine chorioallantoic membrane explants to wild type, ΔvirB2 or ΔbtpB Brucella abortus infection.The Brucella suis type IV secretion system assembles in the cell envelope of the heterologous host Agrobacterium tumefaciens and increases IncQ plasmid pLS1 recipient competenceGenetic resistance to Brucella abortus in the water buffalo (Bubalus bubalis).The epitopic and structural characterization of Brucella suis biovar 2 O-polysaccharide demonstrates the existence of a new M-negative C-negative smooth Brucella serovarType IVB secretion by intracellular pathogens.Heterologous expression of Brucella abortus GroEL heat-shock protein in Lactococcus lactisBrucella abortus rough mutants induce macrophage oncosis that requires bacterial protein synthesis and direct interaction with the macrophage.Role of the Brucella suis lipopolysaccharide O antigen in phagosomal genesis and in inhibition of phagosome-lysosome fusion in murine macrophages.An in vivo high-throughput screening approach targeting the type IV secretion system component VirB8 identified inhibitors of Brucella abortus 2308 proliferation.Design and synthesis of a universal antigen to detect brucellosis.Early transcriptional responses of internalization defective Brucella abortus mutants in professional phagocytes, RAW 264.7.Attenuated signature-tagged mutagenesis mutants of Brucella melitensis identified during the acute phase of infection in mice.Microarray-based identification of differentially expressed genes in intracellular Brucella abortus within RAW264.7 cellsLack of endogenous IL-10 enhances production of proinflammatory cytokines and leads to Brucella abortus clearance in mice.T cell immunity to brucellosis.The asymmetric distribution of the essential histidine kinase PdhS indicates a differentiation event in Brucella abortus.
P2860
Q24545524-2813402C-318A-4FD0-8D4C-658237B3DA84Q27496626-E82966FF-630E-4A07-AAA0-9C56A1EEFC8AQ28475478-D3849060-C5CA-4BC6-A7D0-EE4A2E60692EQ28492359-1BE33AE7-56AA-4CB8-B9BA-D33E3ED425FFQ30152717-E856ADD0-4419-4AF2-9197-AD2A2D6DDA30Q30155240-75FE5496-4864-4405-A4E1-6B50AE92B97FQ30530337-03FAC532-A622-49FE-B12A-ACC1099FB451Q33234895-F5BB51C9-1F73-418B-8B9E-2E406E1C0F98Q33436203-4904A5EC-5F8A-4E03-97F1-0288A96B463DQ33444749-64EEAA9D-0846-4C67-8F00-F312FB447374Q33526847-8B47943F-9941-4251-A7A9-1439DA010E97Q33635179-FFDFC023-2130-4C60-9B7A-E3C002E9AF39Q33719183-71D3D798-9C95-44FA-AD87-9E71DB562481Q33768984-1B7A03CF-F417-4A49-A09E-39B26562EF6EQ33826026-28C6C36E-FC5C-41F9-93C3-FFB3064A0777Q33899699-27D8DF67-54DD-4DFB-8D21-1C30A559DA63Q33988738-D8E830B7-FF66-4DF0-AFDF-2FBAA55CDA71Q34010148-316BAD63-DA90-4476-8E34-92132A481931Q34034020-87E12B1B-35A1-425E-A6BF-558A163E6AA0Q34082091-9662F462-F184-4653-85A5-388B16D19EBFQ34099800-E19EA317-3411-4391-9ABB-A3DA8EEA7FD2Q34111611-F2F544BB-509A-4DEE-8A3D-F27708293225Q34120666-FB538AAC-BFAE-470F-949A-CA704D56FF22Q34155378-B3E31F74-0ECD-4A82-B7F9-86ADB7B04B84Q34258772-2F75B7E4-3E32-4F5B-A73B-83DC73C03B5FQ34301121-84AEF1CE-6328-4C2D-A364-772F037C9A24Q34492716-8BEDC09F-1007-4FB3-AD8F-3DEE273952A8Q34555789-676EAF55-FC62-4DD0-A3E8-848093141790Q34557143-0002E02E-CEF9-435B-8345-48402EDF79ADQ34557340-8FDE13AA-BB8B-43D8-9A1C-A37C5CF65D51Q34601987-11F15CD4-3633-4156-8060-D4462DE3C27FQ34714844-9FBCBEDF-1A68-441C-943D-F63F7F8157FFQ34739706-0A35A212-1273-4E84-BE76-CDDC258B3F27Q34767658-B8E17EEA-68E2-475D-94AA-84A76DE9BB70Q34784741-F96F7071-E941-41F5-A6E2-9054F5C22A25Q34942704-DAE0CF12-C24A-43B9-B4AA-03CC284CE449Q34945859-81EBFD1D-218D-49CB-B16C-3165EA001990Q34999280-15DF11B3-34B8-45DA-A3C2-7CADC3910F23Q35592364-5B195680-87D4-48BF-9225-0A75A03C79BFQ35672009-73B21BBA-4033-447A-B003-00C09EFB7045
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Brucellosis: a worldwide zoonosis.
@ast
Brucellosis: a worldwide zoonosis.
@en
Brucellosis: a worldwide zoonosis.
@nl
type
label
Brucellosis: a worldwide zoonosis.
@ast
Brucellosis: a worldwide zoonosis.
@en
Brucellosis: a worldwide zoonosis.
@nl
prefLabel
Brucellosis: a worldwide zoonosis.
@ast
Brucellosis: a worldwide zoonosis.
@en
Brucellosis: a worldwide zoonosis.
@nl
P2093
P1476
Brucellosis: a worldwide zoonosis.
@en
P2093
Boschiroli ML
Foulongne V
O'Callaghan D
P356
10.1016/S1369-5274(00)00165-X
P577
2001-02-01T00:00:00Z